Tolerability of rifampin monotherapy for latent tuberculosis infection in children

Pediatr Infect Dis J. 2011 Nov;30(11):1014-5. doi: 10.1097/INF.0b013e31823234c9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / therapeutic use*
  • Child
  • Drug Administration Schedule
  • Drug Dosage Calculations
  • Humans
  • Isoniazid / administration & dosage
  • Isoniazid / adverse effects
  • Isoniazid / therapeutic use
  • Latent Tuberculosis / drug therapy*
  • Latent Tuberculosis / epidemiology
  • Latent Tuberculosis / microbiology
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / physiology
  • Patient Compliance
  • Rifampin / administration & dosage
  • Rifampin / therapeutic use*
  • United States / epidemiology

Substances

  • Antitubercular Agents
  • Isoniazid
  • Rifampin